PacBio Expects No Instrument Revenue Before Year's End; Shipped Seven Sequencers as of Sept. 15

The company said it does not expect to recognize revenue on any of its orders before the end of this year. As of June 30, it had a backlog of purchase orders or signed contracts of approximately $15 million and expects to ship these orders by the end of 2011.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.